Aquinox to Present at the 17th Annual Needham Healthcare Conference
Mar 21, 2018 13:00 pm UTC| Business
VANCOUVER, British Columbia, March 21, 2018 -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation,...
Mar 21, 2018 13:00 pm UTC| Business
NEW YORK, March 21, 2018 -- TradeStation, a Monex Group company and award-winning* online broker-dealer and futures commission merchant, will host an exciting “pop-up” event offering participants the chance to “Get a...
GlobalWebIndex and Publicis Media Shine Light on Hispanic Audiences
Mar 21, 2018 12:59 pm UTC| Business
NEW YORK, March 21, 2018 -- A new data set made public today by GlobalWebIndex, in partnership with Publicis Media, sets out to improve advertiser, publisher and agency understanding around the online behaviors,...
One Horizon Completes Acquisition of C-Rod Companies
Mar 21, 2018 12:54 pm UTC| Business
LONDON, March 21, 2018 -- One Horizon Group, Inc. (NASDAQ:OHGI) today announced that it has completed the acquisition of C-Rod, Inc., along with its record label and media content division (collectively, the “C-Rod...
RJD Green, Inc. Announces Earthlinc Environmental Enters Letter of Intent for Property
Mar 21, 2018 12:45 pm UTC| Business
TULSA, OK, March 21, 2018 -- RJD Green, Inc. (OTC: RJDG), today announced the Earthlinc Environmental Division has entered into a non-binding Letter of Intent with Pemco Inc. for the first operating oil gas...
Ocean Rig UDW Inc. Announces $100 Million Prepayment of $450 Million Senior Secured Credit Facility
Mar 21, 2018 12:45 pm UTC| Business
GRAND CAYMAN, Cayman Islands , March 21, 2018 -- Ocean Rig UDW Inc. (NASDAQ:ORIG) (“Ocean Rig” or the “Company”), a global provider of offshore deepwater drilling services, announced today that it has prepaid $100...
Mar 21, 2018 12:45 pm UTC| Business
NEW YORK, March 21, 2018 -- SELLAS Life Sciences Group Inc., (Nasdaq:SLS) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today...